International Waldenstrom's Macroglobulinemia Foundation (IWMF)
Latest Content
The FDA approval of Brukinsa represents another treatment option with fewer side effects in patients with Waldenstrom's macroglobulinema, however it will not serve as a replacement for other therapies.
Advertisement
Advertisement
Trending on CURE
1
Keytruda Combo Approved for Platinum-Resistant Ovarian Cancer
2
FDA Grants Designation to Immunotherapy KB707 for Advanced NSCLC
3
When Cancer Care Becomes a Logistical Balancing Act
4
FDA Clears Phase 2b Study of Teverelix in Advanced Prostate Cancer
5